Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Rader

Circulation

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Circulation|August 5, 2009
Lecithin: cholesterol acyltransferase and atherosclerosis: another high-density lipoprotein story that doesn't quite follow the scriptDaniel J Rader
Circulation|October 1, 2019
Enhancing Atherosclerosis Regression in Diabetic Mice Through Apo AI (Apolipoprotein AI)Daniel J Rader
Circulation|February 15, 2017
Mediterranean Approach to Improving High-Density Lipoprotein FunctionDaniel J Rader
Circulation|March 1, 2006
Emerging therapies targeting high-density lipoprotein metabolism and reverse cholesterol transportDanielle Duffy, Daniel J Rader
Circulation|June 1, 2006
Macrophage reverse cholesterol transport: key to the regression of atherosclerosis?Marina Cuchel, Daniel J Rader
Circulation|February 25, 2020
Polygenic Risk Scores and Coronary Artery Disease: Ready for Prime Time?Michael G Levin, Daniel J Rader
Circulation|September 15, 2004
Cholesteryl ester transfer protein and coronary artery disease: an observation with therapeutic implicationsMegan L Wolfe, Daniel J Rader
Circulation|October 1, 2003
The metabolic syndrome: more than the sum of its parts?Muredach P Reilly, Daniel J Rader
Circulation|March 5, 2014
Lomitapide and mipomersen: two first-in-class drugs for reducing low-density lipoprotein cholesterol in patients with homozygous familial hypercholesterolemiaDaniel J Rader, John J P Kastelein
Circulation|September 6, 2022
Gain-of-Function Variants in Lipid Genes Enhance Biological Insight and Point Toward Therapeutic OpportunitiesSylvia Stankov, Cecilia Vitali, Daniel J Rader
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Circulation|August 5, 2009
Lecithin: cholesterol acyltransferase and atherosclerosis: another high-density lipoprotein story that doesn't quite follow the scriptDaniel J Rader
Circulation|October 1, 2019
Enhancing Atherosclerosis Regression in Diabetic Mice Through Apo AI (Apolipoprotein AI)Daniel J Rader
Circulation|February 15, 2017
Mediterranean Approach to Improving High-Density Lipoprotein FunctionDaniel J Rader
Circulation|March 1, 2006
Emerging therapies targeting high-density lipoprotein metabolism and reverse cholesterol transportDanielle Duffy, Daniel J Rader
Circulation|June 1, 2006
Macrophage reverse cholesterol transport: key to the regression of atherosclerosis?Marina Cuchel, Daniel J Rader
Circulation|February 25, 2020
Polygenic Risk Scores and Coronary Artery Disease: Ready for Prime Time?Michael G Levin, Daniel J Rader
Circulation|September 15, 2004
Cholesteryl ester transfer protein and coronary artery disease: an observation with therapeutic implicationsMegan L Wolfe, Daniel J Rader
Circulation|October 1, 2003
The metabolic syndrome: more than the sum of its parts?Muredach P Reilly, Daniel J Rader
Circulation|March 5, 2014
Lomitapide and mipomersen: two first-in-class drugs for reducing low-density lipoprotein cholesterol in patients with homozygous familial hypercholesterolemiaDaniel J Rader, John J P Kastelein
Circulation|September 6, 2022
Gain-of-Function Variants in Lipid Genes Enhance Biological Insight and Point Toward Therapeutic OpportunitiesSylvia Stankov, Cecilia Vitali, Daniel J Rader
Pageof 5